SGS SA ((CH:SGSN)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SGS SA struck an upbeat tone on its latest earnings call, highlighting record sales, profits, and free cash flow despite sharp currency headwinds. Management stressed broad-based organic growth, strong returns on capital, and disciplined deal-making, while acknowledging pockets of softness in Natural Resources, consulting, and U.S. pharma drug development.
Record sales underpinned by resilient organic growth
SGS reported record full-year sales of CHF 6.95 billion, powered by 5.6% organic growth and 1.7% from acquisitions. Reported growth was a more modest 2.2% as a strong Swiss franc shaved 5.1 percentage points off the top line, underlining how resilient underlying demand had to be to overcome currency pressure.
Margin expansion drives record adjusted operating income
Adjusted operating income reached an all-time high of CHF 1.1 billion, with the margin rising to 16.0%. That represents a 70-basis-point improvement versus 2024 and a 130-basis-point gain versus the 2023 baseline, showing that efficiency programs are translating into tangible profitability gains.
Free cash flow hits new high with strong conversion
Free cash flow came in at a record CHF 774 million, corresponding to a solid 57% cash conversion on adjusted EBITDA. Including CHF 67 million in net proceeds from the disposal of the company’s headquarters, total free cash flow climbed to CHF 841 million, reinforcing balance sheet strength and funding capacity.
EPS growth supported by both operations and disposals
Earnings per share rose to CHF 3.48, up 12.3% year-on-year, benefiting from operational improvement and the HQ disposal gain. Excluding that gain, EPS still advanced to CHF 3.21, a 3.5% increase, suggesting underlying earnings growth even without asset sales.
Efficiency program delivers visible procurement savings
The company’s lean operating model and procurement initiatives have generated CHF 115 million of visible savings in the income statement since 2024. Management said the run-rate reached CHF 150 million by the end of 2025, with another CHF 35 million expected to flow through during 2026 as programs mature.
High returns and moderate leverage support investment
Return on invested capital remained an industry-leading 24%, highlighting the efficiency of SGS’s asset base. Net debt to adjusted EBITDA stood at 1.7 times before closing the ATS deal, providing room for continued investment and acquisitions without overstretching the balance sheet.
Strategic M&A and ATS boost North American scale
The acquisition of Applied Technical Services, which closed in January 2026, marks a significant push to strengthen SGS’s footprint in North America. Alongside ATS, seven bolt-on deals since the last update add roughly CHF 190 million of annualised sales, underscoring a disciplined yet active M&A strategy.
Broad-based growth across divisions and regions
Organic growth was broad-based, with Health & Nutrition up 7.3%, Industries & Environment up 6.5%, Connectivity & Products up 6.4%, Business Assurance up 4.2%, and Natural Resources up 3.4%. Regionally, Asia Pacific grew 7.7%, Latin America surged 13.6%, North America rose 3.9%, and EMEA added 5.3%, with Europe itself up 2.4%.
Sustainability and digital trust gaining strategic traction
Sustainability-related services expanded by roughly 15%, confirming strong underlying demand for ESG-driven solutions. Digital Trust also posted double-digit growth, supported by both organic investments and acquisitions, and remains a key pillar for future double-digit growth potential.
ESG and stakeholder metrics continue to improve
Customer satisfaction rose to 92% as SGS stepped up its training efforts, delivering 7.7 million training hours. The group also maintained leading ESG ratings and secured a second consecutive inclusion in a major ranking of the world’s most sustainable companies, reinforcing its non-financial credentials.
Dividend policy balances returns and growth
The board plans to propose a dividend of CHF 3.20 per share, maintaining an attractive payout for shareholders. The scrip dividend option, which has historically seen more than 60% take-up, helps SGS preserve cash to fund organic investment and M&A while still rewarding investors.
Foreign exchange headwinds mask underlying strength
Currency movements were a major drag, cutting reported sales growth by 5.1% and reducing adjusted operating income by the equivalent of 6.4%, or about 20 basis points of margin. Management warned that, if current exchange rates persist, foreign exchange could trim around 8% from reported growth in the first quarter of 2026.
Reported growth lags strong constant-currency performance
While reported sales rose only 2.2%, constant-currency growth reached 7.3%, combining 5.6% organic and 1.7% M&A contributions. For investors, this gap underlines that operational momentum is stronger than the headline figures suggest once the impact of the stronger Swiss franc is stripped out.
Natural resources and agriculture face cyclical pressure
Natural Resources grew organically by 3.4%, lagging the group average and reflecting softer conditions in some commodity markets. Agriculture was hit particularly hard by a weak crop in Europe and political uncertainty in parts of EMEA, which dampened trading volumes and testing activity.
Consulting softness weighs on business assurance
Within the Business Assurance division, consulting activities remained weak and acted as a brake on performance. Despite strong demand in sustainability and Digital Trust services, this consulting slowdown limited the division’s overall organic growth to 4.2%.
Restructuring and other nonrecurring costs remain a factor
Restructuring expenses declined from prior peaks but still totaled around CHF 45 million in 2025, with guidance of CHF 20–40 million for 2026. Management also pointed out that other nonrecurring items can fluctuate and have historically averaged about CHF 120 million, a factor investors must monitor.
Temporary leverage uptick after ATS acquisition
Following the completion of the ATS deal, SGS expects net debt to EBITDA to temporarily climb to roughly 2.1–2.2 times. The company plans a gradual deleveraging in the following years, banking on robust cash generation and synergy capture to bring leverage back down.
Margin gains to be partly reinvested in innovation
Management positioned the 16% adjusted operating income margin as a minimum floor for 2026 rather than an upper target. They signaled that some margin upside will be reinvested into innovation, digital and AI capabilities, ensuring long-term competitiveness even if not all gains flow directly to earnings.
Performance variability across segments and geographies
Not all areas grew evenly, with certain parts of Connectivity & Products in Europe and the Natural Resources division facing challenges. High prior-year comparables, such as strong post-certification activity in ISO-related services, also made short-term comparisons more difficult in some niches.
Mixed pharma trends with U.S. drug development lagging
Pharma-related activities showed a mixed picture, as clinical research in Europe performed solidly while U.S. drug development remained subdued. This divergence tempered overall Health & Nutrition and pharma momentum, highlighting differing investment cycles between regions.
Timing of savings and synergies introduces uncertainty
Some benefits from efficiency measures and acquisitions are phased in, creating uncertainty over the exact timing of profit uplift. The company highlighted about CHF 35 million of additional procurement savings expected in 2026 and referenced future ATS synergies and other planned savings totaling around CHF 30 million.
Guidance points to continued growth and disciplined margins
For 2026, management guided to 5–7% organic growth and expects more than 5% additional sales from acquisitions, including ATS. They aim to maintain at least a 16% adjusted operating income margin while retaining the flexibility to reinvest surplus in innovation, all against a backdrop of continued FX headwinds and a temporarily higher leverage ratio.
SGS’s latest earnings call painted a picture of a company delivering record financials while investing for the future, even as currency and some end markets pose challenges. For investors, the key messages were robust underlying demand, disciplined capital allocation, and a commitment to sustaining margins while funding digital, sustainability, and M&A-driven growth.